ALBANY, N.Y. (AP) — A national long-term care pharmacy accused of accepting kickbacks from a drug manufacturer has agreed to a settlement of more than $4 million, with New York getting a share of the money.
Attorney General Eric Schneiderman says Kentucky-based Omnicare is settling allegations it requested price concessions from the drug manufacturer Amgen to switch patients suffering from chronic kidney disease and the effects of chemotherapy to Aranesp, an Amgen product.
New York's Medicaid program will be reimbursed more than $664,000 from the settlement, which covers 48 states and the District of Columbia.
An Omnicare spokesman says Friday the company agreed to the settlement to avoid further litigation. It continues to deny any wrongdoing.
Schneiderman's office says Amgen agreed last year to pay $24.9 million in a national settlement of the claims.